We hypothesized that the application of iRGD-functionalized Tam-loaded PS could be a rational strategy to reduce the selection of breast cancer stem cells by Tam and counteract the induction of endocrine resistance by FN. The gene discussed is FN1; the disease is breast carcinoma.